Outcomes of Immunotherapy vs Chemotherapy as First-Line Treatment in Advanced NSCLC: A Meta-analysis of Randomized Clinical Trials

被引：0

作者：

Ponvilawan, B. ^{[1
]}

Sharma, P. ^{[1
]}

Mahadevia, H. ^{[1
]}

Qasim, H. ^{[1
]}

Subramanian, J. ^{[2
]}

Bansal, D. ^{[3
]}

机构：

[1] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA

[2] Inova Schar Canc Inst, Fairfax, VA USA

[3] Univ Missourie Kansas City, St Lukes Canc Inst, Sch Med, Kansas City, KS USA

来源：

关键词：

Non-small cell lung cancer; First-line treatment; Immune checkpoint inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP11.03-17

引用

页码：S627 / S627

页数：1